Project Grant R34DA067263
Award Date 8/1/26
Completion Date 6/30/29
Dollars Obligated $156K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Baltimore, MD 21205, USA
Similar Awards
- The National Institute on Drug Abuse awarded Johns Hopkins University $198,164 on October 17, 2025, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct research examining barriers to medications for opioid use disorder (MOUD) treatment for individuals transitioning from correctional facilities to community settings. The research employs a complex systems approach combining quantitative and qualitative methods. Specific aims include examining the structure and function...
- The National Institute on Drug Abuse awarded The Johns Hopkins University $686,170 under the Drug Use and Addiction Research Programs (CFDA 93.279) on June 15, 2026, to develop and evaluate the Better Together intervention, an eight-session, age-appropriate substance use prevention program for adolescents ages eleven to thirteen exposed to household challenges including parental substance use, parental incarceration, and parental mental health issues, and negative neighborhood contexts including...
- The National Institute on Drug Abuse awarded The Johns Hopkins University $1.731 million on June 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct research on immune mechanisms impacting the blood-brain barrier in people who inject drugs with and without HIV. The research examines how neuroimmune-blood-brain-barrier interactions contribute to cognitive complications among people with a history of injection drug use, particularly those coinfected with HIV....
- The National Institute on Drug Abuse awarded The Johns Hopkins University $427,000 under the Drug Use and Addiction Research Programs (CFDA 93.279) on September 15, 2025, for Project Grant R21DA064465. The recipient will examine HIV, hepatitis C, and sexually transmitted infection co-infection patterns among an existing cohort of 400 rural people who inject drugs in Cabell County, West Virginia, where an ongoing HIV outbreak linked to injection drug use has persisted since 2018. The work...
- The National Institute on Drug Abuse awarded The Johns Hopkins University $100,228 on January 7, 2027, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct a longitudinal study examining how dynamic housing status affects healthcare utilization among people who inject drugs living with and without HIV. The research characterizes longitudinal housing trajectories among people who inject drugs in Baltimore, Maryland, and assesses the causal relationship between housing...
- The National Institute on Drug Abuse awarded New York University $771,043 on March 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct a hybrid type II implementation-effectiveness trial of a peer change agent intervention designed to increase pre-exposure prophylaxis and medication for opioid use disorder uptake among people who inject drugs. The study, titled "A Social Network Approach to Improve HIV Prevention and Substance Use Treatment for People Who...
- The National Institute on Drug Abuse awarded Albert Einstein College of Medicine $756,000 on March 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct formative research on improving pre-exposure prophylaxis (PrEP) engagement among hospitalized people who use substances through addiction consult services. The project, executed through March 2029 in Bronx, New York, comprises three research aims. First, semi-structured interviews with twenty hospitalized people...
- The National Institute on Drug Abuse awarded The Trustees of The University of Pennsylvania $885,939 on July 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to test the effectiveness of a remote intervention designed to reduce HIV and hepatitis C infection risk in rural areas of the United States. The project, submitted in response to RFA-DA-25024 (High Priority HIV and Substance Use Research), examines a virtual social intervention that convenes people with recent...
- The National Institute on Drug Abuse awarded The Miriam Hospital $186,895 on May 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct research evaluating optimal settings for integrated wound care, pre-exposure prophylaxis (PrEP), and medications for opioid use disorder (MOUD) among people who use drugs. The project runs through April 30, 2031, with place of performance in Providence, Rhode Island. The research combines qualitative and quantitative methods to...
- The National Institute on Drug Abuse awarded Duke University $726,750 under the Drug Use and Addiction Research Programs (CFDA 93.279) on August 1, 2026, for development and pilot implementation of a community-partnered digital health platform to enhance HIV pre-exposure prophylaxis (PrEP) linkage and retention among people who use drugs. The project applies human-centered design to develop a tailored digital health platform and implementation protocol for long-acting injectable PrEP delivery...